# iHuman Inc.: Form 20-F for the period ended Dec 31, 2021

- Company: [iHuman Inc.](/companies/ih.md) (CIK 1814423)
- Form: 20-F
- Filed: 2022-04-29
- Accepted by EDGAR: Apr 29, 2022, 16:19 ET
- Period: 2021-12-31
- Accession: 0001104659-22-053581
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1814423/000110465922053581/ih-20211231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1814423/000110465922053581/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2021-01-01 to 2021-12-31 | $148.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2021-01-01 to 2021-12-31 | $44.6m | us-gaap:CostOfRevenue |
| Gross profit | 12 months, 2021-01-01 to 2021-12-31 | $103.7m | us-gaap:GrossProfit |
| Research and development | 12 months, 2021-01-01 to 2021-12-31 | $65.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2021-01-01 to 2021-12-31 | −$8.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months, 2021-01-01 to 2021-12-31 | −$23.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2021-01-01 to 2021-12-31 | −$5.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2021-01-01 to 2021-12-31 | −$0.02 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2021-01-01 to 2021-12-31 | −$0.02 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2021-01-01 to 2021-12-31 | 266,631,802 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2021-01-01 to 2021-12-31 | $6.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2021-01-01 to 2021-12-31 | $5.1m | us-gaap:PaymentsToAcquireProductiveAssets |
| Share repurchases | 12 months, 2021-01-01 to 2021-12-31 | $26.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2021-12-31 | $134.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-12-31 | $159.3m | us-gaap:AssetsCurrent |
| Total assets | at 2021-12-31 | $172.8m | us-gaap:Assets |
| Current liabilities | at 2021-12-31 | $75.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2021-12-31 | $77.3m | us-gaap:Liabilities |
| Shareholders' equity | at 2021-12-31 | $95.5m | us-gaap:StockholdersEquity |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1814423/000110465922053581/ih-20211231x20f.htm

Filed Apr 29, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-053581. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.